Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

162 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux.
Rubenstein JH, Taylor JB. Rubenstein JH, et al. Aliment Pharmacol Ther. 2010 Nov;32(10):1222-7. doi: 10.1111/j.1365-2036.2010.04471.x. Epub 2010 Sep 23. Aliment Pharmacol Ther. 2010. PMID: 20955441 Free PMC article. Review.
A cost-utility analysis of secondary prophylaxis for variceal hemorrhage.
Rubenstein JH, Eisen GM, Inadomi JM. Rubenstein JH, et al. Am J Gastroenterol. 2004 Jul;99(7):1274-88. doi: 10.1111/j.1572-0241.2004.04153.x. Am J Gastroenterol. 2004. PMID: 15233665
Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs.
Rubenstein JH, Laine L. Rubenstein JH, et al. Aliment Pharmacol Ther. 2004 Aug 15;20(4):373-80. doi: 10.1111/j.1365-2036.2004.02092.x. Aliment Pharmacol Ther. 2004. PMID: 15298630 Review.
The cost-effectiveness of biomarkers for predicting the development of oesophageal adenocarcinoma.
Rubenstein JH, Vakil N, Inadomi JM. Rubenstein JH, et al. Aliment Pharmacol Ther. 2005 Jul 15;22(2):135-46. doi: 10.1111/j.1365-2036.2005.02536.x. Aliment Pharmacol Ther. 2005. PMID: 16011672
Relationship between diabetes mellitus and adenocarcinoma of the oesophagus and gastric cardia.
Rubenstein JH, Davis J, Marrero JA, Inadomi JM. Rubenstein JH, et al. Aliment Pharmacol Ther. 2005 Aug 1;22(3):267-71. doi: 10.1111/j.1365-2036.2005.02544.x. Aliment Pharmacol Ther. 2005. PMID: 16091065
Defining a clinically significant adverse impact of diagnosing Barrett's esophagus.
Rubenstein JH, Inadomi JM. Rubenstein JH, et al. J Clin Gastroenterol. 2006 Feb;40(2):109-15. doi: 10.1097/01.mcg.0000196186.19426.4a. J Clin Gastroenterol. 2006. PMID: 16394870
Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy.
Rubenstein JH, Inadomi JM, Brill JV, Eisen GM. Rubenstein JH, et al. Clin Gastroenterol Hepatol. 2007 Mar;5(3):312-8. doi: 10.1016/j.cgh.2006.12.008. Clin Gastroenterol Hepatol. 2007. PMID: 17368230
Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome.
Rubenstein JH, Nojkov B, Korsnes S, Adlis SA, Shaw MJ, Weinman B, Inadomi JM, Saad R, Chey WD. Rubenstein JH, et al. Aliment Pharmacol Ther. 2007 Aug 1;26(3):443-52. doi: 10.1111/j.1365-2036.2007.03393.x. Aliment Pharmacol Ther. 2007. PMID: 17635379
A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma.
Rubenstein JH, Scheiman JM, Anderson MA. Rubenstein JH, et al. Pancreatology. 2007;7(5-6):514-25. doi: 10.1159/000108969. Epub 2007 Oct 1. Pancreatology. 2007. PMID: 17912015
Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus.
Rubenstein JH, Saini SD, Kuhn L, McMahon L, Sharma P, Pardi DS, Schoenfeld P. Rubenstein JH, et al. Am J Gastroenterol. 2008 Apr;103(4):842-9. doi: 10.1111/j.1572-0241.2007.01689.x. Epub 2007 Dec 12. Am J Gastroenterol. 2008. PMID: 18076733
162 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback